Overview of Levofloxacina Richet
| Property | Description |
|---|---|
| Active ingredient | Levofloxacin |
| Form | Tablets, Oral Solution, Injectable Solution |
| Pharmacological class | Fluoroquinolone Antibiotic (Quinolone Class) |
| Common use | Treatment of various bacterial infections |
| Origin | Synthetic (L-isomer) |
What Type of Medicine is Levofloxacina Richet?
Levofloxacina Richet is a prescription-only medicine manufactured by the Richet laboratory, typically associated with markets in Latin America. Its active ingredient is Levofloxacin, which is classified as a powerful broad-spectrum antibiotic. Its primary role is to eliminate harmful bacteria that cause systemic infections throughout the body, such as complicated urinary tract infections or community-acquired pneumonia, which is a typical use scenario for this class of drug.
The active substance belongs to the fluoroquinolone antibiotic class. Levofloxacin is clinically recognized for its effectiveness against a wide spectrum of bacteria and is included on the World Health Organization's List of Essential Medicines. This international inclusion emphasizes its significance as a crucial tool for managing bacterial illnesses globally. The medicine is available in several key dosage forms, including tablets for oral use, as well as a sterile injectable solution for intravenous administration.
Levofloxacin: The L-Isomer Composition and Origin
The core component of the medication is Levofloxacin, a synthetic compound that is the purified L-isomer of the older antibiotic, ofloxacin. Levofloxacin is formulated as a single-component product focused entirely on its specific antibacterial action.
This specific chemical structure is not found naturally; it is chemically synthesized to ensure consistent purity and maximized potency. The designation as the L-isomer is significant because this form carries the vast majority of the desired antibacterial activity, providing a more targeted effect. Its high oral bioavailability, approaching near-complete absorption, simplifies the transition between intravenous and oral preparations during a course of therapy.
How Does Levofloxacin Generally Benefit the Patient?
The general benefit of Levofloxacin is the active elimination of bacteria, which ultimately allows the body to overcome the infection causing the illness. It achieves this benefit through a bactericidal agent function, meaning it directly kills the bacterial cells.
This decisive function stems from its ability to disrupt the microorganisms' essential life processes. Unlike agents that merely slow growth, Levofloxacin interferes with the bacteria’s capacity to copy and manage its DNA, a function critical for reproduction and survival. This action is effective against a wide range of different bacterial types, providing the benefit of a comprehensive approach to clearing systemic infections.
Regulatory References
